Search Results - "Tewes, Frederic"
-
1
Control of the Lung Residence Time of Highly Permeable Molecules after Nebulization: Example of the Fluoroquinolones
Published in Pharmaceutics (23-04-2020)“…Pulmonary drug delivery is a promising strategy to treat lung infectious disease as it allows for a high local drug concentration and low systemic side…”
Get full text
Journal Article -
2
(E, E)-farnesol and myristic acid-loaded lipid nanoparticles overcome colistin resistance in Acinetobacter baumannii
Published in International journal of pharmaceutics (25-12-2024)“…[Display omitted] The rise of colistin-resistant Acinetobacter baumannii has severely limited treatment options for infections caused by this pathogen. While…”
Get full text
Journal Article -
3
Sustained-release microparticle dry powders of chloramphenicol palmitate or thiamphenicol palmitate prodrugs for lung delivery as aerosols
Published in European journal of pharmaceutical sciences (01-10-2019)“…The purpose of this study was to design inhalable sustained-release nanoparticle-in-microparticles, i.e. nano-embedded microparticles, for the lung delivery of…”
Get full text
Journal Article -
4
Amorphous Calcium Carbonate Based-Microparticles for Peptide Pulmonary Delivery
Published in ACS applied materials & interfaces (20-01-2016)“…Amorphous calcium carbonate (ACC) is known to interact with proteins, for example, in biogenic ACC, to form stable amorphous phases. The control of…”
Get full text
Journal Article -
5
In vitro evaluation of Pseudomonas aeruginosa chronic lung infection models: Are agar and calcium-alginate beads interchangeable?
Published in European journal of pharmaceutics and biopharmaceutics (01-10-2019)“…[Display omitted] Animal models of chronic lung infection with P. aeruginosa (PA) are useful tools to improve antibiotic (ATB) treatment. Two main models based…”
Get full text
Journal Article -
6
Assessment of inhaled cationic antibiotics in an in vitro model of Pseudomonas aeruginosa lung biofilm
Published in Microbial pathogenesis (01-12-2024)“…This study aimed to evaluate the efficacy of inhaled cationic antibiotics, including tobramycin (TOB) and colistin (CST), using an in vitro alginate bead model…”
Get full text
Journal Article -
7
Impact of mixed Staphylococcus aureus-Pseudomonas aeruginosa biofilm on susceptibility to antimicrobial treatments in a 3D in vitro model
Published in Scientific reports (13-11-2024)“…Staphylococcus aureus and Pseudomonas aeruginosa are the most common bacteria co-isolated from chronic infected wounds. Their interactions remain unclear but…”
Get full text
Journal Article -
8
Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections
Published in Pharmaceutics (14-03-2022)“…Pulmonary mold infections are life-threatening diseases with high morbi-mortalities. Treatment is based on systemic antifungal agents belonging to the families…”
Get full text
Journal Article -
9
New aerosol formulation to control ciprofloxacin pulmonary concentration
Published in Journal of controlled release (10-02-2018)“…Ciprofloxacin (CIP) apparent permeability across a pulmonary epithelium model can be controlled by the affinity of its complex with a metal cation. The higher…”
Get full text
Journal Article -
10
Moisture diffusion and permeability characteristics of hydroxypropylmethylcellulose and hard gelatin capsules
Published in International journal of pharmaceutics (30-01-2015)“…[Display omitted] The primary objective of this paper is to compare the sorption characteristics of hydroxypropylmethylcellulose (HPMC) and hard gelatin (HG)…”
Get full text
Journal Article -
11
Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous/nanoparticulate microparticles (NPMPs) for inhalation
Published in International journal of pharmaceutics (10-04-2015)“…[Display omitted] A challenge exists to produce dry powder inhaler (DPI) formulations with appropriate formulation stability, biological activity and suitable…”
Get full text
Journal Article -
12
Lipid Nanoparticles Loaded with Farnesol or Geraniol to Enhance the Susceptibility of E. coli MCR-1 to Colistin
Published in Pharmaceutics (01-11-2021)“…Resistance to colistin, one of the antibiotics of last resort against multidrug-resistant Gram-negative bacteria, is increasingly reported. Notably, MCR…”
Get full text
Journal Article -
13
In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa
Published in European journal of pharmaceutics and biopharmaceutics (01-07-2020)“…[Display omitted] A significant limitation of locally delivered treatments for chronic pulmonary infections is often the short residence time within the…”
Get full text
Journal Article -
14
PK-PD Evaluation of Inhaled Microparticles loaded with Ciprofloxacin-Copper complex in a Rat Model of Chronic Pseudomonas aeruginosa Lung Infection
Published in International journal of pharmaceutics: X (01-12-2023)“…The potential gain in efficacy of pulmonary administration over IV administration of some antibiotics such as ciprofloxacin (CIP) may be limited by the short…”
Get full text
Journal Article -
15
Optimization of levofloxacin-loaded crosslinked chitosan microspheres for inhaled aerosol therapy
Published in European journal of pharmaceutics and biopharmaceutics (01-10-2015)“…[Display omitted] The aim of this work was the development of innovative levofloxacin-loaded swellable microspheres (MS) for the dry aerosol therapy of…”
Get full text
Journal Article -
16
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11
Published in Mycoses (01-03-2024)“…Background Meyerozyma guilliermondii is a yeast species responsible for invasive fungal infections. It has high minimum inhibitory concentrations (MICs) to…”
Get full text
Journal Article -
17
Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms
Published in AAPS PharmSciTech (01-07-2019)“…A limitation of antibiotic treatments for P. aeruginosa (PA) chronic pulmonary infections is the reduced efficacy due to sub-therapeutic concentrations at the…”
Get full text
Journal Article -
18
Formulation of rifampicin–cyclodextrin complexes for lung nebulization
Published in Journal of controlled release (14-07-2008)“…Lung administration of antibiotics by nebulization is promising for improving treatment efficiency for pulmonary infections, as it increases drug concentration…”
Get full text
Journal Article -
19
Comparison between Colistin Sulfate Dry Powder and Solution for Pulmonary Delivery
Published in Pharmaceutics (17-06-2020)“…To assess the difference in the fate of the antibiotic colistin (COLI) after its pulmonary delivery as a powder or a solution, we developed a COLI powder and…”
Get full text
Journal Article -
20
Improved In Vitro Anti- Mucorales Activity and Cytotoxicity of Amphotericin B with a Pegylated Surfactant
Published in Journal of fungi (Basel) (27-01-2022)“…The aim of this study was to evaluate the effect of the combination of amphotericin B (AmB) and various non-ionic surfactants on the anti- activity of AmB, the…”
Get full text
Journal Article